Thrombin-activatable fibrinolysis inhibitor-a inhibitors: drugs for sepsis or drugs for disseminated intravascular coagulation?
Carl-Erik
CE
Dempfle
Martin
M
Borggrefe
D000818:Animals; D025901:Carboxypeptidase B2 / Q000008:administration & dosage*; D015331:Cohort Studies; D004195:Disease Models, Animal; D004211:Disseminated Intravascular Coagulation / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D051381:Rats; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D018805:Sepsis / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D016019:Survival Analysis; D016896:Treatment Outcome
D025901:Carboxypeptidase B2